Kineta (KA) Stock Chart & Stock Price History → Why Is Gold On a MASSIVE rally? (From Huge Alerts) (Ad) Free KA Stock Alerts $0.48 0.00 (0.00%) (As of 05/16/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Kineta Stock Price Performance5 Day Performance-13.99%1 Month Performance+0.06%3 Month Performance-83.04%6 Month Performance-85.23%Year-To-Date Performance-86.78%1 Year Performance-84.52% Receive KA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Kineta and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Crypto 101 Media[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Are you monitoring 13,217 cryptocurrencies everyday? If not, you could miss the ONE that can make you wealthy beyond your wildest dreams. You see, while Bitcoin and Ethereum steal all the headlines… It’s often the cryptos flying under the radar that turn small stakes into life-changing windfalls. Claim your free seat by clicking here now. KA Stock Chart for Thursday, May, 16, 2024 KA Chart by TradingView Kineta Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/16/2024$0.48$0.48$0.50$0.4451,830 shs$5.45 million05/15/2024$0.52$0.48-7.69%$0.56$0.39132,850 shs$5.45 million05/14/2024$0.52$0.52+0.04%$0.54$0.5146,615 shs$5.90 million05/13/2024$0.56$0.52-6.86%$0.60$0.50161,004 shs$5.90 million05/10/2024$0.63$0.56-11.59%$0.63$0.5657,567 shs$6.33 million05/09/2024$0.57$0.63+11.34%$0.65$0.54292,557 shs$7.17 million Get the Latest News and Ratings for KA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Kineta and its competitors with MarketBeat's FREE daily newsletter. 05/08/2024$0.58$0.57-1.63%$0.60$0.5578,021 shs$6.44 million05/07/2024$0.58$0.58-0.96%$0.61$0.5736,528 shs$6.54 million05/06/2024$0.59$0.58-1.34%$0.60$0.5679,060 shs$6.61 million05/03/2024$0.56$0.59+5.15%$0.61$0.5367,152 shs$6.70 million05/02/2024$0.56$0.56+0.36%$0.58$0.5056,753 shs$6.37 million05/01/2024$0.56$0.56-0.96%$0.61$0.55157,067 shs$6.35 million04/30/2024$0.59$0.56-4.86%$0.63$0.5463,289 shs$6.19 million04/29/2024$0.61$0.59-2.75%$0.61$0.5947,324 shs$6.50 million04/26/2024$0.64$0.61-4.66%$0.62$0.57130,623 shs$6.69 million04/25/2024$0.62$0.64+3.19%$0.65$0.57182,375 shs$7.01 million04/24/2024$0.67$0.62-7.44%$0.67$0.60172,659 shs$6.80 million04/23/2024$0.63$0.67+5.50%$0.68$0.60310,923 shs$7.34 million04/22/2024$0.53$0.63+20.47%$0.74$0.51828,877 shs$6.96 million04/19/2024$0.49$0.53+7.99%$0.55$0.49478,877 shs$5.78 million04/18/2024$0.47$0.49+3.83%$0.55$0.41848,256 shs$5.35 million04/17/2024$0.48$0.47-2.02%$0.52$0.42729,932 shs$5.15 million04/16/2024$0.34$0.48+41.09%$0.55$0.335.40 million shs$5.26 million04/15/2024$0.36$0.34-6.34%$0.39$0.34167,078 shs$3.73 million04/12/2024$0.44$0.36-17.50%$0.44$0.36163,780 shs$3.98 million04/11/2024$0.37$0.44+18.92%$0.47$0.37555,284 shs$4.82 million04/10/2024$0.43$0.37-13.95%$0.43$0.35437,456 shs$4.06 million04/09/2024$0.54$0.43-20.30%$0.49$0.411.23 million shs$4.71 million04/08/2024$0.56$0.54-3.64%$0.55$0.515.34 million shs$5.91 million04/05/2024$0.56$0.56+0.43%$0.59$0.5366,101 shs$6.14 million04/04/2024$0.57$0.56-2.12%$0.60$0.53100,824 shs$6.11 million04/03/2024$0.49$0.57+15.42%$0.57$0.4756,625 shs$6.24 million04/02/2024$0.51$0.49-2.57%$0.53$0.4640,061 shs$5.41 million04/01/2024$0.53$0.51-3.58%$0.53$0.4745,791 shs$5.55 million03/29/2024$0.53$0.53$0.57$0.41139,857 shs$5.76 million03/28/2024$0.52$0.53+0.77%$0.57$0.41139,453 shs$5.76 million03/27/2024$0.55$0.52-5.58%$0.60$0.5199,010 shs$5.71 million03/26/2024$0.56$0.55-0.65%$0.61$0.55143,000 shs$6.05 million03/25/2024$0.65$0.56-14.49%$0.66$0.50140,331 shs$6.09 million03/22/2024$0.59$0.62+5.12%$0.65$0.5595,107 shs$6.47 millionThe #1 Investment of the Decade… (Ad)Sam Altman, the CEO of OpenAI, has invested $375 million into a breakthrough technology, that legendary financial analyst Porter Stansberry believes… …could be the number-one investment of the decade.To get all the details of this controversial tech – click here now.03/21/2024$0.57$0.59+4.80%$0.73$0.56251,949 shs$6.15 million03/20/2024$0.54$0.57+5.25%$0.58$0.5450,229 shs$5.87 million03/19/2024$0.56$0.54-3.59%$0.57$0.5052,657 shs$5.58 million03/18/2024$0.55$0.56+2.17%$0.62$0.5379,426 shs$5.79 million03/15/2024$0.61$0.55-10.76%$0.67$0.55223,785 shs$5.66 million03/14/2024$0.62$0.61-0.75%$0.62$0.5575,552 shs$6.35 million03/13/2024$0.63$0.62-1.69%$0.64$0.57100,997 shs$6.39 million03/12/2024$0.68$0.63-7.96%$0.76$0.60308,050 shs$6.50 million03/11/2024$0.70$0.68-2.16%$0.76$0.6687,866 shs$7.07 million03/08/2024$0.77$0.69-9.83%$0.79$0.68131,659 shs$7.20 million03/07/2024$0.78$0.77-1.56%$0.81$0.7493,695 shs$7.98 million03/06/2024$0.82$0.78-4.85%$0.90$0.76199,315 shs$8.11 million03/05/2024$1.01$0.82-18.81%$1.05$0.75521,417 shs$8.52 million03/04/2024$0.89$1.01+13.36%$1.33$0.952.08 million shs$10.49 million03/01/2024$0.82$0.89+8.66%$0.97$0.77246,559 shs$9.26 million02/29/2024$2.26$0.82-63.72%$1.73$0.82569,956 shs$8.52 million02/28/2024$2.26$2.26$2.36$2.2627,071 shs$23.48 million02/27/2024$2.32$2.26-2.59%$2.37$2.2512,220 shs$23.48 million02/26/2024$2.52$2.32-7.94%$2.50$2.3024,273 shs$24.11 million02/23/2024$2.61$2.52-3.45%$2.70$2.4714,258 shs$26.18 million02/22/2024$2.60$2.61+0.38%$2.77$2.5636,575 shs$27.12 million02/21/2024$2.60$2.60$2.68$2.555,531 shs$27.01 million02/20/2024$2.83$2.60-8.13%$2.82$2.6020,110 shs$27.02 million02/19/2024$2.83$2.83$2.83$2.644,400 shs$29.40 million02/16/2024$2.60$2.83+8.85%$2.83$2.644,475 shs$29.40 million02/15/2024$2.75$2.60-5.45%$2.80$2.607,909 shs$27.02 million Related Companies: Ainos Stock Chart Hillstream BioPharma Stock Chart Enveric Biosciences Stock Chart ASLAN Pharmaceuticals Stock Chart Pulmatrix Stock Chart Tenax Therapeutics Stock Chart Lixte Biotechnology Stock Chart Yumanity Therapeutics Stock Chart Adial Pharmaceuticals Stock Chart Shuttle Pharmaceuticals Stock Chart Receive KA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Kineta and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:KA) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersGold Set to EXPLODE!Gold Safe ExchangeWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsWhy Is Gold On a MASSIVE rally? Huge AlertsThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingCharles Payne Demystifies OptionsUnstoppable ProsperityBiden FINISHED On June 13th?Paradigm PressHow Biden has already won 2024Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kineta, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.